Arxis Soars in $1.1B IPO on Mission-Critical Tech Demand

BLOOMFIELD, Conn. – April 15, 2026 – Arxis, Inc., a manufacturer of highly engineered components for critical industries, today announced the pricing of its upsized initial public offering, raising approximately $1.13 billion in a powerful debut on the public markets. The company, a portfolio holding of private equity firm Arcline Investment Management, priced its 40.5 million shares at $28.00 each, the top of its expected range, signaling robust investor appetite for its specialized technology.

Shares are set to begin trading on the Nasdaq Global Select Market on April 16 under the ticker symbol “ARXS.” The offering, which was increased from an initial plan of around 37.7 million shares, gives the Bloomfield-based company an estimated market valuation of approximately $11.3 billion. The successful pricing reflects deep confidence from Wall Street in the company's strategic position within the resilient aerospace, defense, and medical technology sectors.

Underwriters, led by Goldman Sachs, Morgan Stanley, and Jefferies, have a 30-day option to purchase an additional 6.075 million shares, potentially bringing the total proceeds even higher. The offering's strength was bolstered by significant anchor orders totaling around $400 million from major institutional investors, including Capital International Investors, T. Rowe Price, and Janus Henderson Investors, underscoring a belief in the company’s long-term growth trajectory.

The Arcline Blueprint for Growth

Arxis's journey to becoming a public heavyweight is a case study in modern private equity strategy. Since its acquisition by Arcline Investment Management in 2019, the company has been transformed through an aggressive and disciplined acquisition-driven model. Arcline, a growth-oriented firm, has guided Arxis through more than 30 acquisitions, consolidating a fragmented landscape of niche component suppliers into a cohesive industrial platform.

This strategy has fueled explosive growth. For the twelve months ending December 31, 2025, Arxis reported revenues of $1.6 billion, a staggering 114% increase from the $743 million reported in 2024. More significantly, the company swung from a net loss of $55 million in 2024 to a net income of $46 million in 2025. This rapid scaling is a direct result of its M&A activity, including the landmark $1.8 billion purchase of Kaman Corporation in 2024, which significantly expanded its portfolio and market reach.

Arcline’s philosophy of building “enduring industrial platforms” rather than pursuing quick flips has allowed Arxis to integrate these disparate businesses, expand its technological capabilities, and create cross-selling synergies. The IPO allows Arcline to realize a portion of its investment while positioning Arxis with the capital structure needed for its next phase of expansion.

A Portfolio of Proprietary Power

At the heart of Arxis's appeal is its business model, which is built on a foundation of proprietary, mission-critical technology. The company does not produce commoditized parts; it designs and manufactures highly specialized electronic and mechanical components that are essential to the performance of complex systems in extreme environments. Approximately 90% of its revenue is generated from these proprietary products.

Crucially, Arxis holds “designed-in” positions on more than 600 distinct platforms across its target markets. This means its components are integral to the original design of everything from fighter jets and commercial airliners to advanced medical imaging machines and industrial robotics. This incumbency creates a powerful competitive moat, ensuring long product lifecycles and a stable, recurring revenue stream from a diversified base of over 5,000 customers.

In 2025, the company's revenue was well-diversified across key sectors: 47% from defense and space, 23% from commercial aerospace, and 30% from industrial technology, which includes medical and semiconductor applications. This balance provides resilience against downturns in any single market. Operationally, Arxis employs a decentralized model supported by its proprietary “Arxis EDGE” data-driven system, which grants its individual business units autonomy while leveraging centralized expertise to drive operational excellence.

Riding Tailwinds in Critical Sectors

The timing of the Arxis IPO capitalizes on powerful secular trends across its core markets. Investor enthusiasm is not just for the company itself, but for the industries it serves. The global aerospace and defense sector is experiencing a surge in activity, with record order backlogs exceeding $2 trillion. Rising geopolitical tensions are driving defense budgets higher globally, while commercial aerospace continues its post-pandemic recovery, fueled by rising passenger demand and the need for fleet renewals.

In this environment, the demand for a resilient and innovative supply chain is paramount. Companies like Arxis, which provide the critical, high-performance components that enable these larger systems, are seen as indispensable partners. Supply chain disruptions in recent years have only highlighted the value of reliable, technologically advanced domestic suppliers.

Simultaneously, the medical technology industry is undergoing a revolution driven by AI, robotics, and connectivity. The expansion of robotic surgery, the proliferation of smart diagnostic tools, and the increasing complexity of medical devices all depend on the kind of sophisticated electronic and mechanical components that Arxis specializes in. As procedures shift to ambulatory surgery centers and remote patient monitoring becomes more common, the need for smaller, more efficient, and more reliable devices will only grow.

Charting the Course as a Public Company

With the infusion of capital from its IPO, Arxis is poised to accelerate its proven growth strategy. The company plans to use the net proceeds primarily to repay outstanding debt under its credit facilities, a move that will de-lever its balance sheet and provide greater financial flexibility. The remaining funds are earmarked for working capital, general corporate purposes, and, crucially, future acquisitions.

The company is led by a management team with deep experience in executing this model. President and CEO Kevin Perhamus and CFO Azad Badakhsh both have extensive track records in acquiring, integrating, and operating engineered components businesses. Their leadership will be critical as Arxis continues to consolidate the market and expand its technological footprint.

By successfully launching one of the year’s most significant industrial IPOs, Arxis has not only validated Arcline’s investment thesis but has also sent a strong signal about the enduring value of specialized American manufacturing. With a fortified balance sheet and a clear mandate for growth, Arxis now begins its next chapter as a publicly traded heavyweight in the world of mission-critical engineering.